Health Canada
- Status: approved
Gonadotropin Releasing Hormone Antagonists Relugolix (Gonadotropin Releasing Hormone Antagonists Relugolix) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Oregon Health and Science University is the originator. The local marketing authorisation holder may differ — check the official source linked above.